Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · June 07, 2023

SARS-CoV-2 mRNA Vaccine Booster in Ofatumumab-Treated Patients With Relapsing MS



Additional Info

Disclosure statements are available on the authors' profiles:

Results on SARS-CoV-2 mRNA Vaccine Booster from an Open-Label Multicenter Study in Ofatumumab-Treated Participants with Relapsing Multiple Sclerosis
Vaccines (Basel) 2023 May 13;11(5)978, T Ziemssen, E Schlegel, M Groth, B Ettle, T Bopp

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading